Cesca Therapeutics Inc. (KOOL) Set to Announce Quarterly Earnings on Wednesday
Cesca Therapeutics Inc. (NASDAQ:KOOL) is set to issue its quarterly earnings data after the market closes on Wednesday, November 15th.
Shares of Cesca Therapeutics Inc. (NASDAQ:KOOL) opened at $3.72 on Wednesday. The company has a quick ratio of 1.67, a current ratio of 2.47 and a debt-to-equity ratio of 0.11. Cesca Therapeutics Inc. has a 1 year low of $2.41 and a 1 year high of $6.44.
Separately, ValuEngine upgraded Cesca Therapeutics from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th.
About Cesca Therapeutics
Cesca Therapeutics Inc is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products.
Receive News & Stock Ratings for Cesca Therapeutics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cesca Therapeutics Inc. and related stocks with our FREE daily email newsletter.